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Summary 
Keratinocyte growth factor (KGF), a recently discovered 18.9 kD member of the fibroblast growth 
factor family has been shown to selectively induce keratinocyte proliferation and differentiation 
in tissue culture. To explore its potential stimulating keratinocyte growth and differentiation 
in vivo,  we analyzed for the influence of KGF on epithelial derived elements within a wound 
created through the cartilage on the rabbit ear. KGF accelerated reepithelialization (p  =  0.004) 
and increased the thickness of the epithelium (p  =  0.0005)  when 4-40/~g/cm 2 recombinant 
KGF was added at the time of wounding. The regenerating epidermis showed normal differentiation 
as detected by cytokeratin immunostaining. Remarkably, however, KGF stimulated proliferation 
and differentiation of early progenitor cells within hair follicles and sebaceous glands in the wound 
bed and adjacent dermis. There was a transient but highly significant increase in specific labeling 
of cycling cells in both basal  and suprabasal  layers that extended into the spinous layer of the 
regenerating epidermis. As an indication of specificity,  the inflammatory cells and fibroblasts 
within the wound were not influenced by KGF. The results indicate that KGF is unique in its 
ability to accelerate reepithelialization and dermal regeneration by targeting multiple epithelial 
elements within the skin. These results suggest that KGF may induce specific epithelial progenitor 
cell lineages within the skin to proliferate and differentiate, and thus may be a critical determinant 
of regeneration of skin. Furthermore, these findings illustrate the potential capacity of this system 
to analyze epithelial differentiation programs and disorders of epidermis, dermal glandular elements, 
and hair follicles. 
K 
eratinocyte growth  factor  (KGF1;  fibroblast  growth 
factor [FGF]  7) was originally purified as a mitogenic 
activity for keratinocytes from an embryonic lung fibroblast 
line (1). KGF was found to be '- 30-45%  homologous to 
the other seven members of the FGF family (2). Unlike acidic 
and basic FGFs, KGF contains a putative signal sequence. KGF 
interacts with a specific splice variant of the bek  (FGFR2) 
receptor, a receptor that is similar to K-sam,  and does not 
bind to fig  (FGFR1)  or its splice variants (3-5).  Although 
acidic FGF also binds the KGF receptor with similar affinity 
as KGF,  acidic FGF binds other FGF receptors as well, and 
thus acidic and basic  FGFs have a greater target cell range 
(e.g., endothelial cells, fibroblasts)  than KGF, which is only 
known to stimulate epithelial cells (1, 2, 6). Basic FGF does 
1Abbreviations used in  this paper: BrdU, bromodeoxyuridine; EGF, 
epidermal  growth  factor;  FGF, fibroblast  growth  factor;  KGF, keratinocyte 
growth factor. 
not bind the KGF receptor, but like acidic FGF,  does bind 
FGFR2. Within the KGF receptor, 49 amino acids are alter- 
natively spliced into the COOH-terminal portion of the third 
Ig loop, which confers binding specificity for KGF (7-9). 
For reasons that are not yet known, KGF appears to stimu- 
late DNA synthesis in keratinocyte lines more strongly than 
either acidic or basic FGF (1, 6). KGF transcripts have been 
identified in stromal cell lines and epithelial tissues that con- 
tain mesenchyme such as the skin, lung, and gastrointestinal 
tracts. In skin, KGF message is found exclusively in the dermis, 
suggesting it is a mesenchymally derived paracrine stimu- 
lator of overlying epithelial tissues (2).  Recently, Werner et 
al. (10) found KGF mRNA was dramatically upregulated more 
than 100-fold in rat excisional wounds after 1 d, suggesting 
it may be an important mediator of epidermal repair in vivo. 
For these reasons, we developed an in vivo model to analyze 
the influence of recombinant rKGF on keratinocytes. The po- 
tent effects of rKGF on progenitor cells of the epidermis and 
pilosebaceous units within the dermis were not anticipated. 
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Recombinant KGF.  Human rKGF was produced in Escherichia 
coli, was purified to homogeneity by conventional techniques, and 
was free of endotoxin. It was assayed in the BALB/MK keratino- 
cyte line, and stimulated half-maximal proliferation at 3.3 ng/ml. 
Modified Rabbit Ear Model.  The  rabbit  ear  model  (11) was 
modified by removing cartilage in addition to the overlying skin 
(see Fig.  1). Thus, it represents a deep "partial thickness" wound 
in which wound contraction is not a variable during healing,  per- 
mitting accurate quantitation of new tissues.  In this model, the 
dermis beneath the cartilage (other side of the ear) becomes the 
wound bed,  and  the dermal adnexae  directly contribute to re- 
epithelialization of the wound, as in conventional partial thickness 
wounds. 
After 0.25 cm  2 wounds were created with a 6-mm trephine, 
rKGF at specified concentrations or vehicle alone (PBS) was ap- 
plied once on the day of surgery, and the wounds were covered 
with Tegaderm occlusive dressing (3M, St. Paul, MN) (7). Wounds 
were harvested from 1 to 7 d after wounding. At sacrifice, each 
wound was bisected;  one section was frozen in optimum cooling 
temperature medium (Miles, Inc., Elkhart, IN) and the second was 
fixed in Omnifix II (A1-Con  Genetics,  Inc.,  Melville,  NY) and 
processed  according  to  routine  histological  methods.  Masson 
Trichrome, oil red o, and immunohistochemical stains were per- 
formed on 3 #m-thin  sections  for each wound. 
Assessment of  ReeFithelialization.  The percent reepithelialization 
of each wound was assessed by the formula: 100  x  [(wound di- 
ameter -  epithelial gap)/(wound diameter)]. The total area of ep- 
ithelium generated in treated and untreated wounds was measured 
via a calibrated Quantimet 520 Image Analyzer (12; Cambridge 
Instruments Ltd., Cambridge, UK). The total amount of epithe- 
lium reflects the depth and extent of migration of newly formed 
epidermis, and was detected on Trichrome stained sections begin- 
ning 1.0 mm lateral to each wound edge to the tip of the regener- 
ating tongue. The average amount of epithelium per wound was 
calculated for each dose group. An analysis of variance and Dun- 
nett's t test was run for each dose against  the control group (Stat- 
view II; Abacus Concepts, Inc., Berkeley,  CA). 
Assessment of Proliferating Cells Using Anti-Bromodeoxyuridine. 
30-60 minutes before sacrifice, each animal received an intravenous 
injection of Bromodeoxyuridine (BrdU) (Aldrich Chemical Co., 
Milwaukee, WI), 50 mg/kg body weight. Paraffin-embedded 3-#m 
sections at each time point after wounding were digested with 0.1% 
protease solution (Sigma Chemical Co., St. Louis, MO), followed 
by treatment with 2 N HC1. Endogenous peroxidase was quenched 
with  3%  H202.  Slides were blocked with  a  10%  solution  of 
normal horse serum in PBS, then incubated with anti-BrdU (13; 
Dako Corp., Carpinteria, CA), diluted 1:400 in 1% BSA. After 
washes, sections were incubated with biotinylated horse anti-mouse 
IgG,  and  placed  into  peroxidase-linked  avidin-biotin  complex 
(Vector Laboratories,  Inc., Burlingame, CA), diluted 1:100 in 1% 
BSA. Slides were then exposed to diaminobenzidine (DAB) (Sigma 
Chemical Co.)  substrate (10 mg DAB,  20 ml PBS, 20 #1 30% 
H202) for 10 min.  Sections were counterstained with hematox- 
ylin. Proliferating cells, in bisected wound sections, were counted 
at a magnification of 400 by a blinded observer using a calibrated 
grid and micrometer rule. BrdU positive basal and suprabasal cells 
in the regenerating tongues of epithelium were counted 1.5 mm 
toward each wound border (total distance,  3 mm) based on estab- 
lished methods (14, 15). Unpaired, two-tailed Student's t tests were 
used to assess significance  at each postwounding day. 
Cytokeratins 10 and 14 Immunostaining.  Cytokeratin 10, a marker 
of differentiated suprabasal keratinocytes in normal skin, was de- 
tected using an anti-human cytokeratin 10 mAb (DE-K10;  Bio- 
Genex Laboratories,  San Ramon, CA). Cytokeratin 14, a marker 
of undifferentiated basal keratinocytes in normal skin, was detected 
using an anti-human cytokeratin 14 mAb (LL002; BioGenex Labora- 
tories). Positive immunostaining was detected using an avidin-biotin 
immunoperoxidase technique as described above. 
Analysis of  Hair Follicle Growth.  Hair follicle growth was asyn- 
chronous, thus morphometric assessment of follicle size or number 
was difficult in tissue sections because of variability. Therefore, as- 
sessments of hair follicles within the wound bed were made in fol- 
licles having more than five BrdU-positive proliferating cells. The 
number of follicles per wound bed, the number of proliferating 
cells per follicle, the total number of proliferating folliculocytes per 
wound bed, and the percentage of all wounds containing prolifer- 
ating foUiculocytes were counted. 
Analysis of Sebaceous Gland Growth.  The number of sebaceous 
glands and proliferating sebocytes  within  the wound bed were 
counted. Oil red o, a stain specific for neutral lipids, was used for 
the identification of mature differentiated sebocytes, and was per- 
formed on frozen sections. 7-#m frozen sections were air dried and 
fixed in zinc-formalin (Anatech, Battle Creek, MI) for 10 min. Slides 
were immersed in 0.3% oil red o (wt/vol; Sigma Chemical Co.) 
in 60% isopropanol for 30 min at room temperature, decolorized 
in 60% isopropanol, and counterstained with hematoxylin. Para- 
metric and nonparametric statistics were used to assess changes in 
hair follicles and sebaceous  glands  in response  to rKGF. 
DermaIExplants.  In some experiments, dermal explant cultures 
were prepared using normal rabbit ear skin obtained during the 
wounding procedure. Cartilage was removed from the 6-mm dermal 
biopsies and each sample was bisected using a single edged surgical 
blade. Explants were cultured in DMEM/Ham's F-12 (50% vol/vol) 
containing 10% fetal bovine serum for 4 d. Half of each sample 
was incubated with 10-160 ng/ml rKGF, the other was incubated 
in media alone. Samples were harvested in zinc-formalin,  processed, 
and sections were stained with hematoxylin and eosin. Assessment 
of whether the epidermis had fully epibolized around the dermis 
was made for each pair of tissue samples and compared via the Wil- 
coxon signed-rank test. 
Results  and Discussion 
Recombinant human KGF was utilized in all experiments. 
To assess the influence of rKGF on skin regeneration, initial 
experiments were performed using the well-established full 
thickness  rabbit  ear  model  (11).  rKGF  did  not  accelerate 
reepithelialization in this rapidly healing wound, but appeared 
to stimulate proliferation of the epidermis  and dermal ado 
nexae on the opposite side of the ear, beneath the cartilage, 
prompting further investigation. Therefore, we modified the 
full thickness rabbit wound model (11) by removing carti- 
lage in addition to dermis and epithelium (Fig. 1). This wound 
contains underlying dermis and heals via sprouting of epi- 
thelial elements within the wound bed, in addition to migra- 
tion of keratinocytes from the wound border, analogous to 
the healing observed in conventional partial thickness wounds. 
Importantly, this wound permitted analysis of the range of 
cells capable of responding  to rKGF. 
To  determine  if  rKGF  enhanced  reepithelialization  of 
wounds  containing adnexae in the wound bed, rKGF was 
added and  the wounds  were harvested at  day 5.  A  highly 
832  KGF Influences Dermal Adnexae in Regenerating Skin Figure  1.  Modified rabbit ear partial thickness dermal wound model. 
The rabbit ear dermal ulcer model (11, 12) was modified to produce a wound 
through the cartilage,  to the dermis on the back side of the ear. 
significant increase in reepithelialization occurred when 1 #g 
rKGF was added to wounds (76.9  +  5.8% rKGF vs. 52.5 
_+  6.3%, controls;/~  =  0.004).  The thickness of the new 
epithelium coveting the wound also was markedly increased 
in a dose-dependent fashion at both 5 and 7 d after wounding 
to nearly twice the area of control wound epithelium at a 
dose of up to  10 #g per wound (40 #g/cm~;  Fig. 2). 
Importantly, histologic  analysis suggested that enhanced 
epithelial regeneration in rKGF-treated wounds occurred via 
migration of outer root sheath keratinocytes within the un- 
derlying dermal wound bed as well as from wound borders 
(Fig. 3), suggesting that rKGF could influence epithelial cells 
within the wound bed as well. These observations are con- 
sistent with the known phenotypic plasticity of  epithelial cells 
within pilosebaceous units which permits them to develop 
into epidermis in vitro, as well as in vivo, within partial thick- 
ness wounds (16). Furthermore, enhanced reepithelialization 
in the wounds exposed to underlying dermis, but not in full 
thickness wounds, suggests that adnexal elements are critical 
targets of rKGF. Granulation tissue formation was not en- 
hanced (Fig. 3), as assessed by quantitative image analysis of 
wound  areas and  volumes,  suggesting  that  rKGF  had  a 
specificity  distinct from platelet-derived  growth factor or basic 
FGF, growth factors that can also activate fibroblasts and en- 
dothdial cells and enhance matrix deposition  (12, 17,  18). 
Because rKGF greatly enhanced epidermal regeneration, 
we sought to determine whether it also enhanced epidermal 
maturation as revealed by immunostaining for cytokeratins 
14 and 10. In unwounded epidermis, cytokeratins 14 and 10 
are found within basal and suprabasal keratinocytes, respec- 
tively. Immunostaining of regenerating epidermis revealed 
that rKGF did not accelerate terminal differentiation of ker- 
atinocytes, as assessed by lack of cytokeratin  10 expression 
in both rKGF-treated  and control wounds (Fig. 4).  How- 
ever, rKGF greatly increased a normal population of less ma- 
ture cytokeratin 14 positive ceUs that had migrated into the 
wound bed (Fig. 4). 5-d-old rKGF-treated wounds also ap- 
peared more intensely stained for cytokeratin 14 than did con- 
trol wounds, suggesting that cytokeratin 14 expression may 
be upregulated in rKGF-treated wounds. These data indicated 
that rKGF does not alter two differentiation markers within 
regenerating epidermis, but augments the number of imma- 
ture keratinocytes present￿9 
Since rKGF enhanced epidermal regeneration but not matu- 
ration, we next sought to quantify and localize keratinocyte 
proliferation within the regenerating epidermis using 5-BrdU, 
an S-phase marker (13). Rabbits  were injected with BrdU 
for 30-60 rain before harvest, and wounds were analyzed 24, 
30, 48, and 120 h after wounding. Only minimal (baseline) 
epidermal proliferation  was observed at 24 h.  After 30 h, 
markedly increased numbers of proliferating basal keratino- 
cytes at the wound margins were detected in rKGF-treated 
wounds, suggesting  that they were stimulated  directly by 
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Figure  2.  Total area of regenerating epithelium at days 5 
and 7 after wounding in rKGF-treated and control wounds. Figure 3.  Proliferation and differentiation of 
keratinocytes. Histologic  analysis  of 10/~g rKGF- 
treated and control  wounds  showing  increased  ker- 
atinocyte proliferation and no increased granula- 
tion tissue in rKGF-treated wounds (x 160, BrdU 
and  hematoxylin counterstain). Note increased 
proliferation of peripheral sebocyte  stem cells in 
the rKGF-treated wound. 
rKGF to enter the cell cycle (p  =  0.05; Fig. 5). In addition, 
nearly twice as many proliferating  suprabasal keratinocytes 
were detected in rKGF-treated wounds (p  =  0.02). By days 
2 and 5, increased numbers of proliferating keratinocytes in 
rKGF-treated wounds were detected primarily in the suprabasal 
layer of the cytokeratin 14 positive neoepidermis, suggesting 
continued proliferation  of undifferentiated  phenotypicaUy basal 
keratinocytes (Fig. 6). The transient burst of basal keratino- 
cyte proliferation detected at 30 h in rKGF-treated wounds 
indicates  self-limited  acceleration  of epithelial  repair  and 
differentiation. 
To better analyze migration  of keratinocytes as a contrib- 
utor to the accelerated repair observed with rKGF, explants 
of rabbit skin were cultured for 4 d in suspension. They were 
analyzed for the potential of the epithelium to undergo epiboly, 
and to fully epithelialize  the bottom dermal  surface of the 
explant in response to rKGF. A  dose-dependent increase in 
epithelial migration around the exposed dermal collagen was 
observed with  maximal  effects  at  160  ng/ml  (Table  1). 
Of particular note, both hair follicles and sebaceous glands 
were considerably larger and more numerous in rKGF-treated 
wounds compared with control wounds. However, because 
the size of the pilosebaceous units was difficult to precisely 
quantify  in  tissue  sections  because  of their  asynchronous 
growth  and  cellular  content,  wounds from BrdU-injected 
rabbits were assessed for the extent of sebocyte and hair fol- 
licular cell proliferation  in response to rKGF. A dose-dependent 
increase in the number of follicles,  and proliferating cells per 
follicle was observed in rKGF-treated wound beds (Table 2). 
Furthermore, increased numbers of proliferating follicles per 
wound were observed, and total numbers of proliferating fol- 
licular  cells were increased in rKGF-treated wounds (Table 
2,  Fig.  7).  Proliferation  was not confined to the bulge re- 
gion,  where the  stem cells are  thought  to reside (19),  but 
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Figure 5.  Proliferation of basal (kfi) and suprabasal (right) keratinocytes. 
BrdU was administered within 1 h of sacrifice, thus proliferation, and not 
migration of proliferating  cells, is being measured. 
Table  1.  Relative Amount  of New Epithelium  in Cultured 
Skin Explants 
rKGF dose  rKGF> paired control 
ng/ml 
2.6  3/6 
10  3/6 
40  4/6 
160  6/6* 
Normal skin biopsies from the rabbit ear were bisected. One half was 
treated with rKGF, the other half served as control. After 4 d of culture, 
cross sections of each biopsy half were evaluated histologically for the 
extent of new epithelium  present  on the dermal surface (epithelializa- 
tion), n  =  6 per dose group. 
p  =  0.014,  Wilcoxon signed rank test. 
Figure 6.  Proliferating basal and suprabasal  ker- 
atinocytes per millimeter  regenerating  epithelial 
tongue 2 d after wounding in 3/zg rKGF-treated 
and untreated wounds (x 320, BrdU and hema- 
toxylin counterstain).  Note increased suprabasal 
keratinocyte  proliferation  in  the  rKGF-treated 
wound. 
836  KGF Influences Dermal Adnexae in Regenerating  Skin Table  2.  Proliferating Hair Follicle Epithelial  Cells and Sebocytes in rKGF-treated Wounds 
rKGF (jug) 
0  1  3  10  P value 
Follicles/wound bed  2.0 + 0.3  3.8 _+ 1.7  6.0 _+ 2.3  4.1 + 1.1  NS 
Proliferating cells/ 
follicle  19.4 _+ 5.2  13.8 _+ 2.2  29.2 _+ 3.6  33.2 _+ 4.3*  0.04* 
Proliferating follicle 
cells/wound bed  33  _+ 2  53 _+ 4  175  _+ 8  138 + 5  NS 
Percent wounds with 
proliferating cells  30  29  67  88  <0.05* 
Glands/wound bed  15  _+ 2  22 _+ 3  31 _+ 3  27 _+ 4  <0.01s 
Proliferating glandular 
cells/wound bed  6 _+ 3  ND  ND  65 + 19 +  <0.015 
5 d wounds from rabbits treated with rKGF or left untreated  were stained  for proliferating  cells using  anti-BrdU immunohistochemistry.  The number 
of proliferating  cells within each follicle,  and within all follicles  in the entire wound  bed was determined  by one individual  blinded to the treatments. 
Because of their asynchronous  growth, only  follicles containing  five or more proliferating  cells were used for the analyses. At least 7 wounds were 
analyzed for each dose group. Mean _+ SE are presented. 
* Kruskal-Wallis test. 
t Chi square test. 
S One-way analysis of variance, Dunnett t test. 
also was observed throughout the hair bulb in the outer root 
sheath. Furthermore, in preliminary experiments, rKGF greatly 
reduces hair loss in a chemotherapy-induced alopecia model 
we have established in rats (Yanagihara, D., and G. F. Pierce, 
unpublished observations).  Taken together, these results sug- 
gest that rKGF may potentiate the anagen, or growth phase 
of hair follicles, although whether hair production is increased 
is not yet known. 
Sebocyte maturation consists of a series of steps in which 
peripheral undifferentiated cells proliferate and subsequently 
migrate inward into the lobules of glands where they gradu- 
ally differentiate into mature sebum-producing cells (20, 21). 
The number of sebaceous glands, and the number of prolifer- 
ating sebocytes,  was  significantly increased  within rKGF- 
treated wounds as seen in Fig. 3 and Table 2. To more selec- 
tively identify differentiation within sebaceous glands, sec- 
tions were stained with oil red o. The results demonstrated 
that  glands  were  markedly hyperplastic  in  rKGF-treated 
wounds, indicating that rKGF enhances proliferation and 
differentiation of sebocytes into sebum-producing cells (Fig. 
7 b).  The influence of rKGF on adnexae was not confined 
to the wound bed and underlying dermis, but was also ob- 
served in the dermis above the cartilage adjacent to the wounds. 
Both epidermal growth factor (EGF) and basic FGF have 
been examined in a similar model of wound healing in the 
rabbit ear (11, 12). Although both EGF and basic FGF can 
stimulate reepithelialization, striking differences when com- 
pared with rKGF were found. Neither EGF nor basic FGF 
influenced proliferation or differentiation of adnexal  struc- 
tures (11). In fact, EGF induces catagen regression and cell 
death within hair follicles and sebaceous glands (22-25, and 
G. F. Pierce,  unpublished observations), and basic FGF in- 
hibits development of the pilosebaceous  units in newborn 
mice (26). 
These results thus indicate that rKGF is uniquely capable 
of directly stimulating multiple epithelial stem cells in the 
skin. The increased  proliferation in follicles and sebaceous 
glands coupled with enhanced reepithelialization  suggest that 
rKGF may directly stimulate putative progenitor cells within 
pilosebaceous  units as well as more mature keratinocytes lo- 
cated in the outer root sheath (16). In support of this obser- 
vation, Guo et al. (27) recently expressed KGF in basal ker- 
atinocytes of mice using the cytokeratin 14 promoter,  and 
found diminished hair follicle morphogenesis from a mul- 
tipotential epithelial cell precursor in the fetus. Taken together, 
both studies (this report and 27) support the notion that KGF 
can alter differentiation pathways within pilosebaceous units 
in embryogenesis and wound healing, and suggest that KGF 
may be important in elucidating the differentiation programs 
of epithelial stem cells. 
An initial burst of basal keratinocyte proliferation coupled 
with more sustained proliferation of emerging suprabasal cells 
and migration of regenerating basal keratinocytes is also likely 
an important contributor to the enhanced reepithelialization 
mediated by rKGF in this modified deep partial thickness 
model. Additional markers of differentiating  keratinocytes will 
be important in defining the relative contributions of pilose- 
baceous units and bordering basal keratinocytes toward wound 
837  Pierce  et al. Figure  7.  Influence  of KGF on dermal adnexae. 
(a) Histologic  analysis  of proliferating hair follicles 
within 1-d-old wounds treated with 3/~g rKGF 
or untreated (x 160, BrdU and hematoxylin  coun- 
terstain). Note increased proliferation within the 
shaft of the follicle,  including the outer root sheath 
and bulge regions (19). (b) Oil red o staining of 
sebaceous  glands treated with 10/~g  rKGF or un- 
treated at the base of 5-d-old wounds (￿  he- 
matoxylin counterstain). 
reepithelialization  in rKGF-treated wounds (28-30).  It also 
would be of interest to determine if rKGF augments or ac- 
celerates expression of specific integrin subunits in keratino- 
cytes  from  healing  wounds,  since  enhanced  expression  of 
suprabasal integrins  a2,  or3, c~6, and 31 has been observed 
in hyperproliferative epidermis and may play a role in migra- 
tion, adhesion,  and terminal differentiation of keratinocytes 
in  wounds  (31,  32). 
The ability to stimulate proliferation and subsequent dif- 
ferentiation of multiple epithelial cell types within the skin, 
coupled with its original isolation from fibroblasts, suggest 
that KGF is a potent paracrine stimulator of the skin regener- 
ative process.  In  support  of this hypothesis,  Werner  et al. 
(10) recently observed marked and rapid induction of KGF 
mRNA  in  the  healing  dermis  of mouse partial  thickness 
wounds. In porcine partial thickness  wounding models,  rKGF 
also was shown to enhance reepithelialization  (33 and G. F. 
Pierce,  unpublished),  and  to  accelerate maturation  of the 
epidermal-dermal junction in healed wounds (33). Our results 
therefore suggest that KGF has a unique target cell spectrum 
compared with the other FGF family members and EGF-like 
growth factors (34), and may be of therapeutic value in dis- 
eases of, or injury to, skin, in which full regeneration  is needed. 
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